Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-01 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion · Restricted Stock Units −2,825 2,826
2020-11-25 von Autenried Paul EVP, Chief Information Officer Sale −3 $63.50 $191 126,698.07
2020-11-24 Dubow Adam SVP,ChiefCompliance&EthicsOff. Sale −900 $63.39 $57K 15,186.15
2020-11-24 von Autenried Paul EVP, Chief Information Officer Sale −20,000 $62.75 $1.3M 126,701.07
2020-11-23 VESSEY RUPERT EVP, Research & Early Dev. Sale −13,421 $61.34 $823K 37,922
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Sale −10,579 $61.25 $648K 46,142
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +14,515 $54.94 $797K 60,657
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +12,233 $54.29 $664K 72,890
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +8,489 $44.70 $379K 81,379
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +8,489 $47.81 $406K 89,868
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +8,487 $38.41 $326K 98,355
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Sale −47,012 $61.31 $2.9M 51,343
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Option (right to buy) −14,515 0
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Option (right to buy) −12,233 12,233
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Option (right to buy) −8,489 16,980
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Option (right to buy) −8,489 16,980
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Option (right to buy) −8,487 16,981
2020-10-30 AHMED NADIM EVP and President, Hematology Exercise or conversion +4,650 30,680
2020-10-30 AHMED NADIM EVP and President, Hematology Shares withheld for taxes −2,291 $58.45 $134K 28,389
2020-10-30 AHMED NADIM EVP and President, Hematology Exercise or conversion · Restricted Stock Units −4,650 0

Page 87 of 90 · 1,795 trades